UNIVERSIDAD PERUANA CAYETANO HEREDIA

LIMA

OncologyGrant-only

What changed

NIH R35 · $0.4M · Physical Biology of Transcriptional Control in Embryonic Development

Jun 2025New grantJun 25, 2025Source filing (opens the source filing in a new tab)

Momentum

38no change

Little recent filing activity, or the events on file have decayed.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R35 · $415k · non-dilutive
Jul 1, 2025
UNIVERSITY OF CALIFORNIA BERKELEY · PI GARCIA, HERNAN GUSTAVO · NIGMS · award ends Jun 30, 2030 · Physical Biology of Transcriptional Control in Embryonic Development
NIH RePORTER · NIH RePORTER 11090740 (opens the source filing in a new tab)
Grant
U01 · $942k · non-dilutive
Sep 1, 2023
UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO · NIAID · award ends May 31, 2028 · A multicenter, randomized controlled trial of single and multiple dose regimes of oxfendazole for mild (one or two lesions) parenchymal brain cysticercosis
NIH RePORTER · NIH RePORTER 11101260 (opens the source filing in a new tab)
Grant
D43 · $290k · non-dilutive
Jul 1, 1999
UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GARCIA, HECTOR HUGO · FIC · award ends Feb 28, 2027 · Training in Infectious Diseases in Peru - Time for Implementation Research
NIH RePORTER · NIH RePORTER 11042152 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 74%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R35 · $0.4M · Physical Biology of Transcriptional Control in Embryonic Development
Jun 2025New grantSource (opens the source filing in a new tab)
NIH U01 · $0.9M · A multicenter, randomized controlled trial of single and multiple dose regimes of oxfendazole for mild (one or two lesions) parenchymal brain cysticercosis
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH D43 · $0.3M · Training in Infectious Diseases in Peru - Time for Implementation Research
Feb 2025Grant renewalSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R35 · $415k · non-dilutive

U01 · $942k · non-dilutive

D43 · $290k · non-dilutive